{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:02:16Z","timestamp":1784289736788,"version":"3.55.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jacep.2024.08.009","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T18:59:01Z","timestamp":1728500341000},"page":"2658-2673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mechanisms of Chemical Atrial Defibrillation by Flecainide and Ibutilide"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5753-1131","authenticated-orcid":false,"given":"Pei-Chi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz","family":"Belardinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen E.","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2024.08.009_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1087057115594589","article-title":"A\u00a0new perspective in the field of cardiac safety testing through the comprehensive in\u00a0vitro proarrhythmia assay paradigm","volume":"21","author":"Fermini","year":"2016","journal-title":"J\u00a0Biomol Screen"},{"key":"10.1016\/j.jacep.2024.08.009_bib2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.annemergmed.2017.07.481","article-title":"Ibutilide effectiveness and safety in the cardioversion of atrial fibrillation and flutter in the community emergency department","volume":"71","author":"Vinson","year":"2018","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacep.2024.08.009_bib3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0002-9149(89)90574-2","article-title":"Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter","volume":"64","author":"Van Gelder","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0002-9149(96)00566-8","article-title":"Safety and risk\/benefit analysis of ibutilide for acute conversion of atrial fibrillation\/flutter","volume":"78","author":"Kowey","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib5","first-page":"322","article-title":"[Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter]","volume":"2","author":"Vergara","year":"2001","journal-title":"Ital Heart J Suppl"},{"issue":"Suppl 4","key":"10.1016\/j.jacep.2024.08.009_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2165\/00003495-198500294-00014","article-title":"Logic and empiricism in the selection of antiarrhythmic agents. The role of drug combinations","volume":"29","author":"Coumel","year":"1985","journal-title":"Drugs"},{"key":"10.1016\/j.jacep.2024.08.009_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ahj.2022.01.001","article-title":"The safety of flecainide for atrial fibrillation in patients with stable coronary artery disease - fact or fallacy","volume":"248","author":"Reiffel","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacep.2024.08.009_bib8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00045391-200211000-00013","article-title":"Ibutilide-induced long QT syndrome and torsade de pointes","volume":"9","author":"Gowda","year":"2002","journal-title":"Am J Ther"},{"issue":"Suppl 1","key":"10.1016\/j.jacep.2024.08.009_bib9","first-page":"S79","article-title":"The role of sodium channel current in modulating transmural dispersion of repolarization and arrhythmogenesis","volume":"17","author":"Antzelevitch","year":"2006","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/FJC.0000000000000510","article-title":"Late INa inhibition as an antiarrhythmic strategy","volume":"70","author":"Burashnikov","year":"2017","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacep.2024.08.009_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0002-9149(96)00565-6","article-title":"Efficacy of ibutilide for termination of atrial fibrillation and flutter","volume":"78","author":"Ellenbogen","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib12","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.94.7.1499","article-title":"Ibutilide and the treatment of atrial arrhythmias. A new drug\u2014almost unheralded\u2014is now available to US physicians","volume":"94","author":"Roden","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.08.009_bib13","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jacc.2004.05.051","article-title":"Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents","volume":"44","author":"Hongo","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib14","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/01.CIR.94.7.1613","article-title":"Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation","volume":"94","author":"Stambler","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.08.009_bib15","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jacep.2022.12.021","article-title":"The feasibility and safety of flecainide use among patients with varying degrees of coronary disease","volume":"9","author":"Kiani","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2024.08.009_bib17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0735-1097(96)00121-0","article-title":"Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study","volume":"28","author":"Ellenbogen","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.amjcard.2023.01.035","article-title":"Perspective on antiarrhythmic drug combinations","volume":"192","author":"Reiffel","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0002-9343(96)00194-5","article-title":"The management of atrial fibrillation","volume":"101","author":"Gilligan","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.jacep.2024.08.009_bib20","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0002-8703(98)70010-9","article-title":"Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation","volume":"136","author":"Abi-Mansour","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacep.2024.08.009_bib21","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0002-9149(99)00927-3","article-title":"Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter","volume":"85","author":"Lindeboom","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1054\/JCPT.2000.8690","article-title":"The actions of ibutilide and class Ic drugs on the slow sodium channel: new insights regarding individual pharmacologic effects elucidated through combination therapies","volume":"5","author":"Reiffel","year":"2000","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jacep.2024.08.009_bib23","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/01.CIR.102.19.2385","article-title":"Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study","volume":"102","author":"Singh","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.08.009_bib24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/clc.4960240709","article-title":"Ibutilide: efficacy and safety in atrial fibrillation and atrial flutter in a general cardiology practice","volume":"24","author":"Eversole","year":"2001","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3122\/jabfm.2011.01.080096","article-title":"Safety and efficacy of ibutilide in cardioversion of atrial flutter\u00a0and fibrillation","volume":"24","author":"Nair","year":"2011","journal-title":"J\u00a0Am Board Fam Med"},{"key":"10.1016\/j.jacep.2024.08.009_bib26","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/FJC.0000000000000892","article-title":"Investigational anti-atrial fibrillation pharmacology and mechanisms by which antiarrhythmics terminate the arrhythmia: where are we in 2020?","volume":"76","author":"Burashnikov","year":"2020","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacep.2024.08.009_bib27","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jacc.2010.08.600","article-title":"Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation","volume":"56","author":"Burashnikov","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib28","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/nrd2112","article-title":"Innovative approaches to anti-arrhythmic drug therapy","volume":"5","author":"Nattel","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jacep.2024.08.009_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0002-8703(97)70118-2","article-title":"Efficacy and safety of sotalol in patients with refractory atrial fibrillation or flutter","volume":"134","author":"Gallik","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacep.2024.08.009_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10840-008-9290-6","article-title":"Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter","volume":"23","author":"Banchs","year":"2008","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib31","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.amjcard.2019.12.041","article-title":"Use of flecainide for the treatment of atrial fibrillation","volume":"125","author":"Echt","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.RES.66.3.789","article-title":"Interactions of flecainide with guinea pig cardiac sodium channels. Importance of activation unblocking to the voltage dependence of recovery","volume":"66","author":"Anno","year":"1990","journal-title":"Circ Res"},{"key":"10.1016\/j.jacep.2024.08.009_bib33","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0002-9149(96)00010-0","article-title":"Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing","volume":"77","author":"Stambler","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib34","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0735-1097(95)00607-9","article-title":"Conversion of atrial flutter by ibutilide is associated with increased atrial cycle length variability","volume":"27","author":"Guo","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002588","article-title":"A\u00a0computational model to predict the effects of class I anti-arrhythmic drugs on ventricular rhythms","volume":"3","author":"Moreno","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jacep.2024.08.009_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vascn.2017.04.002","article-title":"Cardiac voltage-gated ion channels in safety pharmacology: review of the landscape leading to the CiPA initiative","volume":"87","author":"Huang","year":"2017","journal-title":"J\u00a0Pharmacol Toxicol Methods"},{"key":"10.1016\/j.jacep.2024.08.009_bib37","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/srep02100","article-title":"MICE models: superior to the HERG model in predicting Torsade de Pointes","volume":"3","author":"Kramer","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacep.2024.08.009_bib38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.yjmcc.2015.08.015","article-title":"In silico screening of the impact of hERG channel kinetic abnormalities on channel block and susceptibility to acquired long QT syndrome","volume":"87","author":"Romero","year":"2015","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib39","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.hrthm.2006.04.021","article-title":"Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proarrhythmias","volume":"3","author":"Liu","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.08.009_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000658","article-title":"Acute effects of sex steroid hormones on susceptibility to cardiac arrhythmias: a simulation study","volume":"6","author":"Yang","year":"2010","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.jacep.2024.08.009_bib41","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1161\/CIRCRESAHA.119.316404","article-title":"A\u00a0computational pipeline to predict cardiotoxicity: from the atom to the rhythm","volume":"126","author":"Yang","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jacep.2024.08.009_bib42","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/CIRCRESAHA.111.253955","article-title":"Human atrial action potential and Ca2+ model: sinus rhythm and chronic atrial fibrillation","volume":"109","author":"Grandi","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jacep.2024.08.009_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002061","article-title":"Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation","volume":"7","author":"O'Hara","year":"2011","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.jacep.2024.08.009_bib44","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1113\/JP271282","article-title":"In silico prediction of drug therapy in catecholaminergic polymorphic ventricular tachycardia","volume":"594","author":"Yang","year":"2016","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib45","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1529\/biophysj.104.047449","article-title":"A\u00a0mathematical treatment of integrated Ca dynamics within the ventricular myocyte","volume":"87","author":"Shannon","year":"2004","journal-title":"Biophysical J"},{"key":"10.1016\/j.jacep.2024.08.009_bib46","doi-asserted-by":"crossref","first-page":"H29","DOI":"10.1152\/ajpheart.01317.2005","article-title":"Flecainide sensitivity of a Na channel long QT mutation shows an open-channel blocking mechanism for use-dependent block","volume":"291","author":"Zhu","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib47","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3389\/fphys.2019.01105","article-title":"Acetylcholine delays atrial activation to facilitate atrial fibrillation","volume":"10","author":"Bayer","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib48","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1126\/science.7973648","article-title":"Electrical turbulence in three-dimensional heart muscle","volume":"266","author":"Winfree","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jacep.2024.08.009_bib49","doi-asserted-by":"crossref","first-page":"7922","DOI":"10.1073\/pnas.0701895104","article-title":"Drift and breakup of spiral waves in reaction-diffusion-mechanics systems","volume":"104","author":"Panfilov","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacep.2024.08.009_bib50","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3389\/fphys.2017.01059","article-title":"Global optimization of ventricular myocyte model to multi-variable objective improves predictions of drug-induced torsades de pointes","volume":"8","author":"Krogh-Madsen","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib51","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0735-1097(95)00424-6","article-title":"Assessment of reverse use-dependent blocking actions of class III antiarrhythmic drugs by 24-hour Holter electrocardiography","volume":"27","author":"Okada","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/047002142X.ch18","article-title":"TRIad: foundation for proarrhythmia (triangulation, reverse use dependence and instability)","volume":"266","author":"Hondeghem","year":"2005","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.jacep.2024.08.009_bib53","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1161\/01.CIR.103.15.2004","article-title":"Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic","volume":"103","author":"Hondeghem","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.08.009_bib54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mbs.2006.09.023","article-title":"Voltage noise influences action potential duration in cardiac myocytes","volume":"208","author":"Tanskanen","year":"2007","journal-title":"Math Biosci"},{"key":"10.1016\/j.jacep.2024.08.009_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003202","article-title":"Determinants of beat-to-beat variability of repolarization duration in the canine ventricular myocyte: a computational analysis","volume":"9","author":"Heijman","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.jacep.2024.08.009_bib56","first-page":"558","article-title":"[Anisotropy and reentrant ventricular tachycardia: experimental model in the isolated rabbit heart]","volume":"43","author":"Brugada","year":"1990","journal-title":"Revista espanola de cardiologia"},{"key":"10.1016\/j.jacep.2024.08.009_bib57","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/hrt.48.2.140","article-title":"Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man","volume":"48","author":"Hellestrand","year":"1982","journal-title":"Br Heart J"},{"key":"10.1016\/j.jacep.2024.08.009_bib58","article-title":"Left ventricular diameter and risk stratification for sudden cardiac death","volume":"3","author":"Narayanan","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacep.2024.08.009_bib59","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.bjp.0704784","article-title":"Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine","volume":"136","author":"Paul","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacep.2024.08.009_bib60","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1124\/jpet.112.198887","article-title":"A\u00a0novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias","volume":"344","author":"Belardinelli","year":"2013","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jacep.2024.08.009_bib61","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.123.012454","article-title":"Effect of flecainide and ibutilide alone and in combination to terminate and prevent recurrence of atrial fibrillation","volume":"17","author":"Burashnikov","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib62","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1540-8167.2005.40677.x","article-title":"The mechanism of pause-induced torsade de pointes in long QT syndrome","volume":"16","author":"Liu","year":"2005","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib63","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0008-6363(99)00035-8","article-title":"Pause induced early afterdepolarizations in the long QT syndrome: a simulation study","volume":"42","author":"Viswanathan","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacep.2024.08.009_bib64","first-page":"66","article-title":"K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes","volume":"269","author":"Slawsky","year":"1994","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jacep.2024.08.009_bib65","first-page":"101","article-title":"Preferential block of late sodium current in the LQT3 \u0394KPQ mutant by the class IC antiarrhythmic flecainide","author":"Nagatomo","year":"2000","journal-title":"Molecular Pharmacol"},{"key":"10.1016\/j.jacep.2024.08.009_bib66","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1161\/CIRCULATIONAHA.110.000661","article-title":"Late sodium current contributes to the reverse rate-dependent effect of IKr inhibition on ventricular repolarization","volume":"123","author":"Wu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.08.009_bib67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/europace\/euq382","article-title":"Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation","volume":"13","author":"Aliot","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2024.08.009_bib68","doi-asserted-by":"crossref","first-page":"26B","DOI":"10.1016\/0002-9149(84)90498-3","article-title":"Electrophysiologic properties of flecainide acetate","volume":"53","author":"Estes","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib69","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1161\/01.CIR.92.5.1300","article-title":"Determinants and mechanisms of flecainide-induced promotion of ventricular tachycardia in anesthetized dogs","volume":"92","author":"Ranger","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.08.009_bib70","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/FJC.0000000000000804","article-title":"Pulmonary delivery of antiarrhythmic drugs for rapid conversion of new-onset atrial fibrillation","volume":"75","author":"Verrier","year":"2020","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacep.2024.08.009_bib71","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.010204","article-title":"Open-label, multicenter study of flecainide acetate oral inhalation solution for acute conversion of recent-onset, symptomatic atrial fibrillation to sinus rhythm","volume":"15","author":"Crijns","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib72","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.ehj.2004.04.030","article-title":"Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset","volume":"25","author":"Reisinger","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2024.08.009_bib73","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/CIRCULATIONAHA.107.704890","article-title":"Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine","volume":"116","author":"Burashnikov","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.08.009_bib74","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48890","article-title":"Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block","volume":"8","author":"Tomek","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.jacep.2024.08.009_bib75","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yjmcc.2016.09.011","article-title":"Convergence of models of human ventricular myocyte electrophysiology after global optimization to recapitulate clinical long QT phenotypes","volume":"100","author":"Mann","year":"2016","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib76","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.yjmcc.2011.12.003","article-title":"Pathophysiology of the cardiac late Na current and its potential as a drug target","volume":"52","author":"Moreno","year":"2012","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib77","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yjmcc.2016.08.011","article-title":"A\u00a0computational model predicts adjunctive pharmacotherapy for cardiac safety via selective inhibition of the late cardiac Na current","volume":"99","author":"Yang","year":"2016","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib78","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1113\/jphysiol.2014.279554","article-title":"A\u00a0computational modelling approach combined with cellular electrophysiology data provides insights into the therapeutic benefit of targeting the late Na+ current","volume":"593","author":"Yang","year":"2015","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib79","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jacep.2023.10.024","article-title":"Toward digital twin technology for precision pharmacology","volume":"10","author":"Yang","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib80","doi-asserted-by":"crossref","first-page":"H1615","DOI":"10.1152\/ajpheart.00243.2011","article-title":"Mechanisms of atrial-selective block of Na(+) channels by ranolazine: II. Insights from a mathematical model","volume":"301","author":"Nesterenko","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib81","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1113\/JP272883","article-title":"Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeutics","volume":"595","author":"Chiamvimonvat","year":"2017","journal-title":"J\u00a0Physiol"},{"issue":"Suppl 4","key":"10.1016\/j.jacep.2024.08.009_bib82","doi-asserted-by":"crossref","first-page":"iv30","DOI":"10.1093\/europace\/euu230","article-title":"In-silico assessment of the dynamic effects of amiodarone and dronedarone on human atrial patho-electrophysiology","volume":"16","author":"Loewe","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2024.08.009_bib83","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1113\/JP272864","article-title":"Potassium channels in the heart: structure, function and regulation","volume":"595","author":"Grandi","year":"2017","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib84","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4330\/wjc.v7.i2.76","article-title":"Flecainide: current status and perspectives in arrhythmia management","volume":"7","author":"Andrikopoulos","year":"2015","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jacep.2024.08.009_bib85","doi-asserted-by":"crossref","first-page":"15631","DOI":"10.1073\/pnas.1004021107","article-title":"Flecainide increases Kir2.1 currents by interacting with cysteine 311, decreasing the polyamine-induced rectification","volume":"107","author":"Caballero","year":"2010","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24007515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24007515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T06:55:17Z","timestamp":1735023317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X24007515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":85,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2405500X24007515"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2024.08.009","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of Chemical Atrial Defibrillation by Flecainide and Ibutilide","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2024.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}